Sun Pharma Q2 Results : Profit falls 36% YoY to Rs 1,989 crore on exceptional charges
30 octobre 2026
Sun Pharma Q2 Results: Revenue from operations rose 12% YoY to Rs 16,199 crore from Rs 14,478 crore in Q2 of last financial year, supported by strong growth in its domestic formulations business and emerging markets.
Site référencé: The Economic Times